A new pet for myeloma

Blood

Volumn 114, Issue 10, 2009, Pages 2007-2008

  Dimopoulos, Meletios Athanassios ^a   Moulopoulos, Lia A ^a   Terpos, Evangelos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EVENT FREE SURVIVAL; FALSE POSITIVE RESULT; HUMAN; MULTIPLE MYELOMA; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 70449584881     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-06-224196     Document Type: Note

References (9)

1. Bartel TB, Haessler J, Brown TLY, et al. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood. 2009;114(10):2068-2076.
2. Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R. Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol. 2005;184(4):1199-1204. (Pubitemid 43821897)
3. Dimopoulos MA, Terpos E, Comenzo RL, et al. International Myeloma Working Group (IMWG) consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma. Leukemia. 2009;in press. PubMed doi:10.1038/leu.2009.89.
4. Mulligan ME, Badros AZ. PET/CT and MR imaging in myeloma. Skeletal Radiol. 2007;36(1):5-16.
5. Durie BG, Waxman AD, D'Agnolo A, Williams CM. Whole-body F-FDG PET identifies high-risk myeloma. J Nucl Med. 2002;43(11):1457-1463. (Pubitemid 35285870)
6. Hillner BE, Siegel BA, Shields AF, et al. Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the National Oncologic PET Registry. J Nucl Med. 2008;49(12):1928-1935.
7. Fonti R, Salvatore B, Quarantelli M, et al. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma. J Nucl Med. 2008;49(2):195-200. (Pubitemid 351225656)
8. Gorospe L, Raman S, Echeveste J, Avril N, Herrero Y, Hernandez S. Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun. 2005;26(8):671-687. (Pubitemid 41073368)
9. Zamagni E, Nanni C, Patriarca F, et al. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica. 2007;92(1):50-55. (Pubitemid 46232657)